Literature DB >> 24057067

[How acrophobia impairs visual exploration and gait].

G Kugler1, D Huppert, E Schneider, T Brandt.   

Abstract

The life-time prevalence of visual height intolerance is 28 % in the general population. More than 50 % of those affected suffer from an impairment of daily behavior and quality of life when confronted with heights. Simultaneous measurements of spontaneous eye and head movements of these subjects while looking from a balcony revealed that visual exploration of the surroundings was restricted compared to that of control subjects. Spontaneous head movements were severely diminished and saccadic eye movements were reduced. Gaze in space was preferably directed towards structures on the horizon. Those susceptible to visual height intolerance exhibited a cautious slowing of gait with small and precarious steps. Restriction of visual exploration during locomotion in a complex terrain may result in falls because obstacles can be overlooked.

Entities:  

Mesh:

Year:  2013        PMID: 24057067     DOI: 10.1007/s00115-013-3905-6

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  17 in total

1.  Attention bias of anxious youth during extended exposure of emotional face pairs: an eye-tracking study.

Authors:  Tomer Shechner; Johanna M Jarcho; Jennifer C Britton; Ellen Leibenluft; Daniel S Pine; Eric E Nelson
Journal:  Depress Anxiety       Date:  2012-07-19       Impact factor: 6.505

2.  The mechanism of physiological height vertigo. I. Theoretical approach and psychophysics.

Authors:  T Brandt; F Arnold; W Bles; T S Kapteyn
Journal:  Acta Otolaryngol       Date:  1980 May-Jun       Impact factor: 1.494

3.  Deconstructing acrophobia: physiological and psychological precursors to developing a fear of heights.

Authors:  Carlos M Coelho; Guy Wallis
Journal:  Depress Anxiety       Date:  2010-09       Impact factor: 6.505

Review 4.  Mechanisms of attentional biases towards threat in anxiety disorders: An integrative review.

Authors:  Josh M Cisler; Ernst H W Koster
Journal:  Clin Psychol Rev       Date:  2009-12-14

Review 5.  Specific phobia: a review of DSM-IV specific phobia and preliminary recommendations for DSM-V.

Authors:  Richard T LeBeau; Daniel Glenn; Betty Liao; Hans-Ulrich Wittchen; Katja Beesdo-Baum; Thomas Ollendick; Michelle G Craske
Journal:  Depress Anxiety       Date:  2010-02       Impact factor: 6.505

6.  Specific fears and phobias in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).

Authors:  Marja F I A Depla; Margreet L ten Have; Anton J L M van Balkom; Ron de Graaf
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-11-30       Impact factor: 4.328

7.  EyeSeeCam: an eye movement-driven head camera for the examination of natural visual exploration.

Authors:  Erich Schneider; Thomas Villgrattner; Johannes Vockeroth; Klaus Bartl; Stefan Kohlbecher; Stanislavs Bardins; Heinz Ulbrich; Thomas Brandt
Journal:  Ann N Y Acad Sci       Date:  2009-05       Impact factor: 5.691

8.  Differential effects of absent visual feedback control on gait variability during different locomotion speeds.

Authors:  M Wuehr; R Schniepp; C Pradhan; J Ilmberger; M Strupp; T Brandt; K Jahn
Journal:  Exp Brain Res       Date:  2012-10-30       Impact factor: 1.972

9.  Consequences of visual height intolerance for quality of life: a qualitative study.

Authors:  Florian Schäffler; Martin Müller; Doreen Huppert; Thomas Brandt; Theresa Tiffe; Eva Grill
Journal:  Qual Life Res       Date:  2013-08-22       Impact factor: 4.147

Review 10.  Anxiety and perceptual-motor performance: toward an integrated model of concepts, mechanisms, and processes.

Authors:  Arne Nieuwenhuys; Raôul R D Oudejans
Journal:  Psychol Res       Date:  2011-10-29
View more
  1 in total

1.  Balance control and anti-gravity muscle activity during the experience of fear at heights.

Authors:  Max Wuehr; Guenter Kugler; Roman Schniepp; Maria Eckl; Cauchy Pradhan; Klaus Jahn; Doreen Huppert; Thomas Brandt
Journal:  Physiol Rep       Date:  2014-02-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.